Exercise May Be Best Medicine for Breast Cancer Survivors

CINCINNATI—University of Cincinnati (UC) scientists believe exercise may be a critical component of rehabilitation and recovery for more than 2 million women who have survived breast cancer.

 

Beverly Reigle, PhD, is leading a pilot study to determine whether a regular exercise program—started just one day after breast cancer surgery—can improve the functional abilities and quality of life of breast cancer survivors.

 

“The assault a woman’s body takes from breast cancer—both from the actual disease and the treatment—affects what she can do physically and mentally,” says Reigle, assistant professor of nursing at UC and principal investigator of the study. “These women have active lives—they’re mothers, grandmothers and professionals in the workforce. Life can’t and shouldn’t stop for breast cancer.”

 

Researchers are recruiting about 25 study participants aged 45 or older who have had breast cancer surgery (mastectomy or lumpectomy and lymph node evaluation) and chosen not to undergo immediate reconstruction.

 

Prior to surgery, a physical therapist measures the woman’s range of motion, upper body strength and arm circumference. This data is used to benchmark strength, flexibility and stamina after treatment. Arm circumference is also used to monitor for lymphedema, a condition in which the lymphatic channels that carry fluid to and from tissue become clogged and swollen.

 

Women are divided at random into two groups. One day after surgery, supervised by a physician therapist, the experimental group starts an 18-week exercise program that includes light lower- and upper-body weight training. A physical therapist meets one-on-one with the patient for the first six weeks, and then the women transition into the University Fitness Center’s “Strong Women” program, a more intense group fitness class focused on strength, flexibility and balance.

 

The control group receives an instructional pamphlet and verbal encouragement to do the exercises.

 

“The problem is that there is no consensus in the medical community on rehabilitation guidelines for breast cancer survivors, so women don’t know what activities they can safely do after surgery,” explains Elizabeth Shaughnessy, MD, PhD, associate professor of surgery at UC and study collaborator.

 

“This study intervenes at the point of impairment—surgery—to help promote continued physical strength, endurance and flexibility,” she adds. “A low-impact exercise regimen started immediately following surgery may prove beneficial without compromising medical recovery.”

 

For more information on this trial, contact Reigle at (513) 558-5276. To learn more about breast cancer clinical trials at UC’s Barrett Cancer Center, contact Ruth Steele at (513) 584-1337.

A ftness instructor works with a breast cancer survivor on an exercise routine.

A ftness instructor works with a breast cancer survivor on an exercise routine.

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.